-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data-repository-reviews-charter-140305.pdf
June 01, 2012 - − The list of potential board members will be reviewed and each potential board
member will be discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
March 01, 2012 - As discussed above, the descriptors of the study design considerations
should be brief. … As discussed previously, the authors of the FRN
report should encourage creativity and emphasize that … are derived from the Alberta report, and are commonly used in
association with the study designs discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/module-iii-points-of-engagement-in-the-ehc-program.pdf
May 29, 2025 - Module III: Points of Engagement in the EHC Program
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-disposition-comments.pdf
May 14, 2025 - We have discussed both MCSTs selected for
the Vanguard trial in Table 1 and have added
additional information … We
believe that we have appropriately and
thoroughly discussed the strengths and
limitations of each
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
September 15, 2014 - For
some specific studies some key aspects are not well-
described or are not discussed in the text … description of this study to
show this unusual finding.
60 Peer Reviewer 2 Results Page 163, As discussed … the original 2009 report.
117 Public comment:
John Aloia
Line 337 Line 337: The cost should be discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
August 31, 2017 - As discussed in
later sections of our review, the
subgroup analyses were quite weak
and did not appear … As discussed previously,
there is a serious mismatch between
the ambitious aims of the report in the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
December 20, 2018 - Selected
PROs were discussed in the text, and the remainder are
found in the tables. … Comment Response
Peer
Reviewer #1
Discussion Limitations: Some weakness of the NWMA were well
discussed … P88: Patient discontinuation rates varied significantly across
the RCTs and observational studies discussed … Reasons for this variation and how it
may impact on the applicability of the results should be
discussed … Section Comment Response
missing even more trials as there might have been cases
where authors had discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
September 01, 2011 - specifically in the field of transcranial
magnetic stimulation (TMS), is ongoing and the publications
discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-216-telehealth-disposition-comments.pdf
April 24, 2019 - CER 216 Disposition of Comments Report: Telehealth for Acute and Chronic Care Consultations
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Telehealth for Acute and Chronic Care Consultations
Draft review available for public comment from May 29, 2018 to June 26, 2018.
Res…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_disposition-comments.pdf
January 27, 2016 - So the heavily contextual nature of
this approach should be similarly discussed
in the strengths and … not be grouped with
others because of the
variability of component
combinations and had to be
discussed … peer review
consensus about the
challenges of measuring
resistance and appropriate
prescribing (discussed … Perhaps this should be discussed,
with a set of options.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - Key Considerations for Including or Excluding NRSIs
Section 3 discussed the strengths and limitations … As discussed in Section 1, RCTs, particularly explanatory RCTs, generally are designed to
determine … As discussed in Section
7, confounding is an important threat to validity of NRSIs. … Interpreting Results From NRSIs
As discussed in Section 7, when interpreting results of NRSIs, it is … Where inconsistencies are detected, their likely sources should be explored and discussed.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - Key Considerations for Including or Excluding NRSIs
Section 3 discussed the strengths and limitations … As discussed in Section 1, RCTs, particularly explanatory RCTs, generally are designed to
determine … As discussed in Section
7, confounding is an important threat to validity of NRSIs. … Interpreting Results From NRSIs
As discussed in Section 7, when interpreting results of NRSIs, it is … Where inconsistencies are detected, their likely sources should be explored and discussed.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
October 25, 2011 - effects model.
1 P15 ln 40 Exec summary KQ1 – describe Type III and IV
monitors before these are discussed … The key questions are appropriate and well
formulated
We have discussed this with our Task Order Officer … the full report (page 15, near bottom, Chapter 4 page 131):
Of note, where interventions are not discussed … Numerous
theoretical and research issues are also
discussed that help the reader to carefully
interpret … Limitations of the
included studies are discussed in a thoughtful
and objective manner.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-269-respectful-maternity-care-summary.pdf
January 01, 2024 - Methods are discussed in detail in the full report and in
Appendix A.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research.pdf
April 15, 2019 - Some reports discussed the potential for using data captured in
EHRs during routine clinical care to … While use of standardized outcome measures is important for the reasons discussed
19
earlier in … These are discussed further in the following section. … These issues, together with recommended best practices, are discussed further
below. … The review of existing initiatives identified three issues related to metadata, as discussed in the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
January 07, 2013 - Disposition of Comments Report for Assessment and Management of Chronic Cough
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1371
Published Online: January 7, 2013
Comparative Effectiveness Research Review Disposition of Comments Repor…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-212-urinary-incontinence-disposition-comments.pdf
August 08, 2018 - Furthermore, assumptions and limitations
need to be discussed for the specific methods
implemented … Thank you
Methods Peer Reviewer #3 I prefer to see definitions of 'meaningful
clinical differences' discussed … For instance, in neither the
exec summary or the report itself is this issue
discussed. … We have,
however, more clearly discussed the evidence pertinent to
the specific populations, as subanalyses … Limiting the review to non surgical treatments
is a fair limitation of scope, as most of the
techniques discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/healthcare-algorithms-agenda-for-March-23.pdf
May 29, 2025 - Agenda: Impact of Healthcare Algorithms on Racial and Ethnic Disparities
1
IMPACT OF HEALTHCARE ALGORITHMS ON RACIAL AND ETHNIC DISPARITIES
IN HEALTH AND HEALTHCARE
AGENDA
March 2–3, 2023
National Institutes of Health (NIH) Natcher Conference Center
45 Center Drive, Building 45, Bethesda, MD 20892 …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
March 01, 2011 - SMD and RoM are
discussed in detail in subsequent sections. … The issues of missing individuals and missing study-level data will be
discussed briefly. … The
difference in handling skewed data was discussed as one of the reasons that the two analyses … For example, Ma
et al.
37
discussed a nonparametric method that utilizes U-statistic theory. … Furukawa
et al. also discussed how imputing SD applies to SMD, and more information on imputing SD
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/data-repository-reviews_white-paper.pdf
September 01, 2012 - including the specifics of the functioning, role and responsibilities of the governing
body would be discussed … developed in partnership with the governing body.
8
Conclusion
Herein, we have discussed